nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.215	0.534	CrCtD
Hydrocortisone—Progesterone—uterine cancer	0.188	0.466	CrCtD
Hydrocortisone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0518	0.234	CbGbCtD
Hydrocortisone—SHBG—Progesterone—uterine cancer	0.0343	0.155	CbGbCtD
Hydrocortisone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0276	0.125	CbGbCtD
Hydrocortisone—NR3C1—Progesterone—uterine cancer	0.0183	0.0826	CbGbCtD
Hydrocortisone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.0129	0.0451	CrCrCtD
Hydrocortisone—Eplerenone—Progesterone—uterine cancer	0.0112	0.0393	CrCrCtD
Hydrocortisone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0358	CrCrCtD
Hydrocortisone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0358	CrCrCtD
Hydrocortisone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.00975	0.0341	CrCrCtD
Hydrocortisone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.00975	0.0341	CrCrCtD
Hydrocortisone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00949	0.0429	CbGbCtD
Hydrocortisone—Formestane—Progesterone—uterine cancer	0.0094	0.0329	CrCrCtD
Hydrocortisone—ABCG2—Dactinomycin—uterine cancer	0.00936	0.0423	CbGbCtD
Hydrocortisone—Dydrogesterone—Progesterone—uterine cancer	0.00892	0.0312	CrCrCtD
Hydrocortisone—Drospirenone—Progesterone—uterine cancer	0.00892	0.0312	CrCrCtD
Hydrocortisone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00892	0.0312	CrCrCtD
Hydrocortisone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.00871	0.0394	CbGbCtD
Hydrocortisone—CYP3A7—Progesterone—uterine cancer	0.00871	0.0394	CbGbCtD
Hydrocortisone—Spironolactone—Progesterone—uterine cancer	0.0085	0.0298	CrCrCtD
Hydrocortisone—Potassium Canrenoate—Progesterone—uterine cancer	0.0085	0.0298	CrCrCtD
Hydrocortisone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.00824	0.0288	CrCrCtD
Hydrocortisone—Megestrol acetate—Progesterone—uterine cancer	0.00778	0.0272	CrCrCtD
Hydrocortisone—Levonorgestrel—Progesterone—uterine cancer	0.00778	0.0272	CrCrCtD
Hydrocortisone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.00766	0.0268	CrCrCtD
Hydrocortisone—Medrysone—Progesterone—uterine cancer	0.00718	0.0251	CrCrCtD
Hydrocortisone—Danazol—Progesterone—uterine cancer	0.00718	0.0251	CrCrCtD
Hydrocortisone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.00716	0.0251	CrCrCtD
Hydrocortisone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.00694	0.0243	CrCrCtD
Hydrocortisone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00692	0.0242	CrCrCtD
Hydrocortisone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.00674	0.0236	CrCrCtD
Hydrocortisone—CYP3A5—Progesterone—uterine cancer	0.00654	0.0296	CbGbCtD
Hydrocortisone—ABCG2—Carboplatin—uterine cancer	0.00629	0.0284	CbGbCtD
Hydrocortisone—CYP2C8—Progesterone—uterine cancer	0.00628	0.0284	CbGbCtD
Hydrocortisone—Norethindrone—Progesterone—uterine cancer	0.00624	0.0219	CrCrCtD
Hydrocortisone—Hydrocortamate—Progesterone—uterine cancer	0.00624	0.0219	CrCrCtD
Hydrocortisone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.00619	0.0217	CrCrCtD
Hydrocortisone—Cortisone acetate—Progesterone—uterine cancer	0.00605	0.0212	CrCrCtD
Hydrocortisone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00603	0.0211	CrCrCtD
Hydrocortisone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00603	0.0211	CrCrCtD
Hydrocortisone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00603	0.0211	CrCrCtD
Hydrocortisone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.00588	0.0206	CrCrCtD
Hydrocortisone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0056	0.0196	CrCrCtD
Hydrocortisone—Fluoxymesterone—Progesterone—uterine cancer	0.0054	0.0189	CrCrCtD
Hydrocortisone—ABCG2—Etoposide—uterine cancer	0.00528	0.0239	CbGbCtD
Hydrocortisone—Testosterone Propionate—Progesterone—uterine cancer	0.00526	0.0184	CrCrCtD
Hydrocortisone—Fludrocortisone—Progesterone—uterine cancer	0.00526	0.0184	CrCrCtD
Hydrocortisone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.00523	0.0183	CrCrCtD
Hydrocortisone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00523	0.0183	CrCrCtD
Hydrocortisone—Methyltestosterone—Progesterone—uterine cancer	0.00513	0.0179	CrCrCtD
Hydrocortisone—Testosterone—Progesterone—uterine cancer	0.00456	0.016	CrCrCtD
Hydrocortisone—Prednisolone—Progesterone—uterine cancer	0.00447	0.0156	CrCrCtD
Hydrocortisone—ABCB1—Progesterone—uterine cancer	0.00425	0.0192	CbGbCtD
Hydrocortisone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.0174	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—uterine cancer	0.0036	0.0163	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—uterine cancer	0.00337	0.0153	CbGbCtD
Hydrocortisone—CYP3A5—Etoposide—uterine cancer	0.00293	0.0132	CbGbCtD
Hydrocortisone—CYP2C8—Etoposide—uterine cancer	0.00281	0.0127	CbGbCtD
Hydrocortisone—CYP3A4—Progesterone—uterine cancer	0.00255	0.0115	CbGbCtD
Hydrocortisone—ABCB1—Etoposide—uterine cancer	0.0019	0.00861	CbGbCtD
Hydrocortisone—ANXA1—oviduct—uterine cancer	0.00187	0.106	CbGeAlD
Hydrocortisone—SHBG—semen—uterine cancer	0.0017	0.0963	CbGeAlD
Hydrocortisone—ABCB1—Doxorubicin—uterine cancer	0.0013	0.00587	CbGbCtD
Hydrocortisone—CYP3A4—Etoposide—uterine cancer	0.00114	0.00516	CbGbCtD
Hydrocortisone—ANXA1—exocrine gland—uterine cancer	0.00108	0.061	CbGeAlD
Hydrocortisone—CYP3A4—Doxorubicin—uterine cancer	0.000778	0.00352	CbGbCtD
Hydrocortisone—CYP11B2—renal system—uterine cancer	0.000639	0.0361	CbGeAlD
Hydrocortisone—ANXA1—myometrium—uterine cancer	0.000599	0.0338	CbGeAlD
Hydrocortisone—ANXA1—epithelium—uterine cancer	0.00047	0.0265	CbGeAlD
Hydrocortisone—ANXA1—uterine cervix—uterine cancer	0.000466	0.0263	CbGeAlD
Hydrocortisone—ANXA1—smooth muscle tissue—uterine cancer	0.000453	0.0256	CbGeAlD
Hydrocortisone—ANXA1—decidua—uterine cancer	0.000444	0.0251	CbGeAlD
Hydrocortisone—ANXA1—renal system—uterine cancer	0.000436	0.0246	CbGeAlD
Hydrocortisone—ANXA1—endometrium—uterine cancer	0.000421	0.0238	CbGeAlD
Hydrocortisone—ANXA1—mammalian vulva—uterine cancer	0.000408	0.023	CbGeAlD
Hydrocortisone—ANXA1—uterus—uterine cancer	0.000388	0.0219	CbGeAlD
Hydrocortisone—ANXA1—female reproductive system—uterine cancer	0.000349	0.0197	CbGeAlD
Hydrocortisone—ANXA1—female gonad—uterine cancer	0.000318	0.0179	CbGeAlD
Hydrocortisone—ANXA1—vagina—uterine cancer	0.000316	0.0178	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—uterine cancer	0.0003	0.0169	CbGeAlD
Hydrocortisone—SHBG—endometrium—uterine cancer	0.000282	0.0159	CbGeAlD
Hydrocortisone—SHBG—uterus—uterine cancer	0.000259	0.0147	CbGeAlD
Hydrocortisone—SLCO1A2—renal system—uterine cancer	0.000242	0.0137	CbGeAlD
Hydrocortisone—SHBG—female reproductive system—uterine cancer	0.000233	0.0132	CbGeAlD
Hydrocortisone—ABCG2—myometrium—uterine cancer	0.000226	0.0127	CbGeAlD
Hydrocortisone—SHBG—female gonad—uterine cancer	0.000212	0.012	CbGeAlD
Hydrocortisone—SHBG—vagina—uterine cancer	0.000211	0.0119	CbGeAlD
Hydrocortisone—Dydrogesterone—PGR—uterine cancer	0.000211	0.113	CrCbGaD
Hydrocortisone—NR3C1—myometrium—uterine cancer	0.000208	0.0117	CbGeAlD
Hydrocortisone—ANXA1—lymph node—uterine cancer	0.000204	0.0115	CbGeAlD
Hydrocortisone—ABCG2—uterine cervix—uterine cancer	0.000176	0.00992	CbGeAlD
Hydrocortisone—CYP2C8—renal system—uterine cancer	0.000169	0.00954	CbGeAlD
Hydrocortisone—ABCG2—decidua—uterine cancer	0.000167	0.00945	CbGeAlD
Hydrocortisone—CYP2C8—endometrium—uterine cancer	0.000163	0.00923	CbGeAlD
Hydrocortisone—NR3C1—epithelium—uterine cancer	0.000163	0.00922	CbGeAlD
Hydrocortisone—CYP3A5—uterine cervix—uterine cancer	0.000163	0.00921	CbGeAlD
Hydrocortisone—NR3C1—uterine cervix—uterine cancer	0.000162	0.00914	CbGeAlD
Hydrocortisone—ABCG2—endometrium—uterine cancer	0.000159	0.00897	CbGeAlD
Hydrocortisone—NR3C1—smooth muscle tissue—uterine cancer	0.000157	0.00888	CbGeAlD
Hydrocortisone—NR3C1—decidua—uterine cancer	0.000154	0.00871	CbGeAlD
Hydrocortisone—ABCG2—mammalian vulva—uterine cancer	0.000154	0.00868	CbGeAlD
Hydrocortisone—CYP3A5—renal system—uterine cancer	0.000153	0.00861	CbGeAlD
Hydrocortisone—NR3C1—renal system—uterine cancer	0.000151	0.00855	CbGeAlD
Hydrocortisone—ABCG2—uterus—uterine cancer	0.000146	0.00827	CbGeAlD
Hydrocortisone—NR3C1—endometrium—uterine cancer	0.000146	0.00826	CbGeAlD
Hydrocortisone—NR3C1—mammalian vulva—uterine cancer	0.000142	0.00799	CbGeAlD
Hydrocortisone—CYP2C8—female reproductive system—uterine cancer	0.000135	0.00764	CbGeAlD
Hydrocortisone—Danazol—CCL2—uterine cancer	0.000135	0.0722	CrCbGaD
Hydrocortisone—NR3C1—uterus—uterine cancer	0.000135	0.00762	CbGeAlD
Hydrocortisone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000133	0.071	CrCbGaD
Hydrocortisone—Megestrol acetate—PGR—uterine cancer	0.000127	0.0677	CrCbGaD
Hydrocortisone—CYP2C8—vagina—uterine cancer	0.000122	0.00691	CbGeAlD
Hydrocortisone—NR3C1—female reproductive system—uterine cancer	0.000121	0.00685	CbGeAlD
Hydrocortisone—ABCG2—female gonad—uterine cancer	0.00012	0.00676	CbGeAlD
Hydrocortisone—ABCG2—vagina—uterine cancer	0.000119	0.00672	CbGeAlD
Hydrocortisone—CYP3A4—renal system—uterine cancer	0.000114	0.00646	CbGeAlD
Hydrocortisone—ABCB1—myometrium—uterine cancer	0.000111	0.00629	CbGeAlD
Hydrocortisone—CYP3A5—female gonad—uterine cancer	0.000111	0.00628	CbGeAlD
Hydrocortisone—Drospirenone—PGR—uterine cancer	0.000111	0.0592	CrCbGaD
Hydrocortisone—CYP3A5—vagina—uterine cancer	0.00011	0.00624	CbGeAlD
Hydrocortisone—NR3C1—female gonad—uterine cancer	0.00011	0.00623	CbGeAlD
Hydrocortisone—NR3C1—vagina—uterine cancer	0.00011	0.00619	CbGeAlD
Hydrocortisone—CYP3A4—female reproductive system—uterine cancer	9.17e-05	0.00518	CbGeAlD
Hydrocortisone—Levonorgestrel—PGR—uterine cancer	9.04e-05	0.0483	CrCbGaD
Hydrocortisone—ABCB1—epithelium—uterine cancer	8.74e-05	0.00493	CbGeAlD
Hydrocortisone—ABCB1—uterine cervix—uterine cancer	8.66e-05	0.00489	CbGeAlD
Hydrocortisone—ABCB1—decidua—uterine cancer	8.25e-05	0.00466	CbGeAlD
Hydrocortisone—Danazol—PGR—uterine cancer	8.23e-05	0.044	CrCbGaD
Hydrocortisone—ABCB1—renal system—uterine cancer	8.1e-05	0.00458	CbGeAlD
Hydrocortisone—Spironolactone—PGR—uterine cancer	7.89e-05	0.0421	CrCbGaD
Hydrocortisone—ABCB1—endometrium—uterine cancer	7.83e-05	0.00442	CbGeAlD
Hydrocortisone—ABCG2—lymph node—uterine cancer	7.7e-05	0.00435	CbGeAlD
Hydrocortisone—ABCB1—mammalian vulva—uterine cancer	7.58e-05	0.00428	CbGeAlD
Hydrocortisone—Medroxyprogesterone Acetate—PGR—uterine cancer	7.39e-05	0.0395	CrCbGaD
Hydrocortisone—Norethindrone—PGR—uterine cancer	7.32e-05	0.0391	CrCbGaD
Hydrocortisone—ABCB1—uterus—uterine cancer	7.22e-05	0.00408	CbGeAlD
Hydrocortisone—NR3C1—lymph node—uterine cancer	7.09e-05	0.004	CbGeAlD
Hydrocortisone—Betamethasone—PGR—uterine cancer	6.71e-05	0.0358	CrCbGaD
Hydrocortisone—ABCB1—female reproductive system—uterine cancer	6.49e-05	0.00366	CbGeAlD
Hydrocortisone—Levonorgestrel—CYP19A1—uterine cancer	6.2e-05	0.0331	CrCbGaD
Hydrocortisone—ABCB1—female gonad—uterine cancer	5.91e-05	0.00333	CbGeAlD
Hydrocortisone—ABCB1—vagina—uterine cancer	5.87e-05	0.00331	CbGeAlD
Hydrocortisone—Levonorgestrel—ESR1—uterine cancer	5.7e-05	0.0305	CrCbGaD
Hydrocortisone—Danazol—CYP19A1—uterine cancer	5.65e-05	0.0302	CrCbGaD
Hydrocortisone—Myalgia—Dactinomycin—uterine cancer	5.57e-05	0.00116	CcSEcCtD
Hydrocortisone—Hypersensitivity—Progesterone—uterine cancer	5.56e-05	0.00116	CcSEcCtD
Hydrocortisone—Dermatitis contact—Doxorubicin—uterine cancer	5.55e-05	0.00116	CcSEcCtD
Hydrocortisone—Oesophagitis—Epirubicin—uterine cancer	5.54e-05	0.00116	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Epirubicin—uterine cancer	5.51e-05	0.00115	CcSEcCtD
Hydrocortisone—Discomfort—Dactinomycin—uterine cancer	5.5e-05	0.00115	CcSEcCtD
Hydrocortisone—Ecchymosis—Epirubicin—uterine cancer	5.49e-05	0.00114	CcSEcCtD
Hydrocortisone—Fluoxymesterone—ESR1—uterine cancer	5.44e-05	0.029	CrCbGaD
Hydrocortisone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	5.43e-05	0.00113	CcSEcCtD
Hydrocortisone—Asthenia—Progesterone—uterine cancer	5.42e-05	0.00113	CcSEcCtD
Hydrocortisone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	5.41e-05	0.00113	CcSEcCtD
Hydrocortisone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	5.41e-05	0.00113	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Epirubicin—uterine cancer	5.4e-05	0.00113	CcSEcCtD
Hydrocortisone—Skin exfoliation—Doxorubicin—uterine cancer	5.36e-05	0.00112	CcSEcCtD
Hydrocortisone—Testosterone—CYP11A1—uterine cancer	5.35e-05	0.0286	CrCbGaD
Hydrocortisone—Pruritus—Progesterone—uterine cancer	5.34e-05	0.00111	CcSEcCtD
Hydrocortisone—Oedema—Dactinomycin—uterine cancer	5.34e-05	0.00111	CcSEcCtD
Hydrocortisone—Fluid retention—Doxorubicin—uterine cancer	5.33e-05	0.00111	CcSEcCtD
Hydrocortisone—Infection—Dactinomycin—uterine cancer	5.3e-05	0.0011	CcSEcCtD
Hydrocortisone—Neuropathy—Doxorubicin—uterine cancer	5.27e-05	0.0011	CcSEcCtD
Hydrocortisone—Danazol—ESR1—uterine cancer	5.2e-05	0.0278	CrCbGaD
Hydrocortisone—Dry eye—Doxorubicin—uterine cancer	5.19e-05	0.00108	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP11A1—uterine cancer	5.18e-05	0.0277	CrCbGaD
Hydrocortisone—Diarrhoea—Progesterone—uterine cancer	5.17e-05	0.00108	CcSEcCtD
Hydrocortisone—Oesophagitis—Doxorubicin—uterine cancer	5.13e-05	0.00107	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Doxorubicin—uterine cancer	5.1e-05	0.00106	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Epirubicin—uterine cancer	5.09e-05	0.00106	CcSEcCtD
Hydrocortisone—Anorexia—Dactinomycin—uterine cancer	5.09e-05	0.00106	CcSEcCtD
Hydrocortisone—Eye disorder—Etoposide—uterine cancer	5.08e-05	0.00106	CcSEcCtD
Hydrocortisone—Ecchymosis—Doxorubicin—uterine cancer	5.08e-05	0.00106	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Epirubicin—uterine cancer	5.06e-05	0.00106	CcSEcCtD
Hydrocortisone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.04e-05	0.00105	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Doxorubicin—uterine cancer	5e-05	0.00104	CcSEcCtD
Hydrocortisone—Dizziness—Progesterone—uterine cancer	4.99e-05	0.00104	CcSEcCtD
Hydrocortisone—Immune system disorder—Etoposide—uterine cancer	4.91e-05	0.00102	CcSEcCtD
Hydrocortisone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	4.91e-05	0.00102	CcSEcCtD
Hydrocortisone—Eczema—Epirubicin—uterine cancer	4.9e-05	0.00102	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	4.86e-05	0.00101	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Epirubicin—uterine cancer	4.86e-05	0.00101	CcSEcCtD
Hydrocortisone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	4.84e-05	0.00101	CcSEcCtD
Hydrocortisone—Vomiting—Progesterone—uterine cancer	4.8e-05	0.001	CcSEcCtD
Hydrocortisone—Methyltestosterone—CYP19A1—uterine cancer	4.77e-05	0.0255	CrCbGaD
Hydrocortisone—Rash—Progesterone—uterine cancer	4.76e-05	0.000992	CcSEcCtD
Hydrocortisone—Dermatitis—Progesterone—uterine cancer	4.76e-05	0.000991	CcSEcCtD
Hydrocortisone—Headache—Progesterone—uterine cancer	4.73e-05	0.000986	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Doxorubicin—uterine cancer	4.71e-05	0.000981	CcSEcCtD
Hydrocortisone—Increased appetite—Epirubicin—uterine cancer	4.69e-05	0.000977	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Doxorubicin—uterine cancer	4.69e-05	0.000976	CcSEcCtD
Hydrocortisone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.68e-05	0.000975	CcSEcCtD
Hydrocortisone—Medroxyprogesterone Acetate—ESR1—uterine cancer	4.66e-05	0.0249	CrCbGaD
Hydrocortisone—Decreased appetite—Dactinomycin—uterine cancer	4.64e-05	0.000967	CcSEcCtD
Hydrocortisone—Betamethasone—CYP19A1—uterine cancer	4.6e-05	0.0246	CrCbGaD
Hydrocortisone—Fatigue—Dactinomycin—uterine cancer	4.6e-05	0.000959	CcSEcCtD
Hydrocortisone—Pain—Dactinomycin—uterine cancer	4.56e-05	0.000951	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Epirubicin—uterine cancer	4.55e-05	0.000948	CcSEcCtD
Hydrocortisone—Eczema—Doxorubicin—uterine cancer	4.53e-05	0.000945	CcSEcCtD
Hydrocortisone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	4.52e-05	0.000943	CcSEcCtD
Hydrocortisone—Cardiac failure—Epirubicin—uterine cancer	4.51e-05	0.000941	CcSEcCtD
Hydrocortisone—Lethargy—Epirubicin—uterine cancer	4.49e-05	0.000937	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Doxorubicin—uterine cancer	4.49e-05	0.000937	CcSEcCtD
Hydrocortisone—Nausea—Progesterone—uterine cancer	4.48e-05	0.000935	CcSEcCtD
Hydrocortisone—Osteoarthritis—Epirubicin—uterine cancer	4.4e-05	0.000918	CcSEcCtD
Hydrocortisone—Feeling abnormal—Dactinomycin—uterine cancer	4.4e-05	0.000916	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Etoposide—uterine cancer	4.39e-05	0.000915	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Dactinomycin—uterine cancer	4.36e-05	0.000909	CcSEcCtD
Hydrocortisone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.35e-05	0.000906	CcSEcCtD
Hydrocortisone—Increased appetite—Doxorubicin—uterine cancer	4.34e-05	0.000904	CcSEcCtD
Hydrocortisone—Affect lability—Epirubicin—uterine cancer	4.34e-05	0.000903	CcSEcCtD
Hydrocortisone—Rash—Medroxyprogesterone Acetate—uterine cancer	4.31e-05	0.000899	CcSEcCtD
Hydrocortisone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.31e-05	0.000898	CcSEcCtD
Hydrocortisone—Headache—Medroxyprogesterone Acetate—uterine cancer	4.29e-05	0.000893	CcSEcCtD
Hydrocortisone—Progesterone—PGR—uterine cancer	4.27e-05	0.0228	CrCbGaD
Hydrocortisone—Malaise—Etoposide—uterine cancer	4.27e-05	0.000889	CcSEcCtD
Hydrocortisone—Vertigo—Etoposide—uterine cancer	4.25e-05	0.000886	CcSEcCtD
Hydrocortisone—Abdominal pain—Dactinomycin—uterine cancer	4.22e-05	0.000879	CcSEcCtD
Hydrocortisone—Body temperature increased—Dactinomycin—uterine cancer	4.22e-05	0.000879	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.21e-05	0.000878	CcSEcCtD
Hydrocortisone—Cardiac arrest—Epirubicin—uterine cancer	4.19e-05	0.000873	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—uterine cancer	4.18e-05	0.00087	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—uterine cancer	4.17e-05	0.00087	CcSEcCtD
Hydrocortisone—Loss of consciousness—Etoposide—uterine cancer	4.16e-05	0.000867	CcSEcCtD
Hydrocortisone—Lethargy—Doxorubicin—uterine cancer	4.16e-05	0.000867	CcSEcCtD
Hydrocortisone—Convulsion—Etoposide—uterine cancer	4.1e-05	0.000854	CcSEcCtD
Hydrocortisone—Hypertension—Etoposide—uterine cancer	4.09e-05	0.000851	CcSEcCtD
Hydrocortisone—Osteoarthritis—Doxorubicin—uterine cancer	4.08e-05	0.000849	CcSEcCtD
Hydrocortisone—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.06e-05	0.000847	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—uterine cancer	4.04e-05	0.000841	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Epirubicin—uterine cancer	4.02e-05	0.000838	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—uterine cancer	4.01e-05	0.000836	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—uterine cancer	4.01e-05	0.000835	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	4e-05	0.000834	CcSEcCtD
Hydrocortisone—Discomfort—Etoposide—uterine cancer	3.98e-05	0.00083	CcSEcCtD
Hydrocortisone—Hypersensitivity—Dactinomycin—uterine cancer	3.93e-05	0.000819	CcSEcCtD
Hydrocortisone—Dexamethasone—PGR—uterine cancer	3.9e-05	0.0208	CrCbGaD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—uterine cancer	3.88e-05	0.00081	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—uterine cancer	3.88e-05	0.00081	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—uterine cancer	3.87e-05	0.000808	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Etoposide—uterine cancer	3.86e-05	0.000805	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—uterine cancer	3.86e-05	0.000805	CcSEcCtD
Hydrocortisone—Infection—Etoposide—uterine cancer	3.84e-05	0.0008	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—uterine cancer	3.83e-05	0.000799	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—uterine cancer	3.83e-05	0.000798	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—uterine cancer	3.8e-05	0.00214	CbGeAlD
Hydrocortisone—Tachycardia—Etoposide—uterine cancer	3.77e-05	0.000785	CcSEcCtD
Hydrocortisone—Skin disorder—Etoposide—uterine cancer	3.75e-05	0.000782	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—uterine cancer	3.74e-05	0.000778	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Etoposide—uterine cancer	3.73e-05	0.000778	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—uterine cancer	3.73e-05	0.000778	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—uterine cancer	3.72e-05	0.000776	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—uterine cancer	3.71e-05	0.000773	CcSEcCtD
Hydrocortisone—Anorexia—Etoposide—uterine cancer	3.68e-05	0.000767	CcSEcCtD
Hydrocortisone—Diarrhoea—Dactinomycin—uterine cancer	3.65e-05	0.000761	CcSEcCtD
Hydrocortisone—Hypotension—Etoposide—uterine cancer	3.61e-05	0.000752	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—uterine cancer	3.59e-05	0.000749	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	3.59e-05	0.000749	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—uterine cancer	3.55e-05	0.000739	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—uterine cancer	3.54e-05	0.000737	CcSEcCtD
Hydrocortisone—Paraesthesia—Etoposide—uterine cancer	3.47e-05	0.000723	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—uterine cancer	3.46e-05	0.000722	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—uterine cancer	3.45e-05	0.00072	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—uterine cancer	3.44e-05	0.000718	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—uterine cancer	3.39e-05	0.000707	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—uterine cancer	3.39e-05	0.000707	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—uterine cancer	3.39e-05	0.000707	CcSEcCtD
Hydrocortisone—Rash—Dactinomycin—uterine cancer	3.36e-05	0.000701	CcSEcCtD
Hydrocortisone—Decreased appetite—Etoposide—uterine cancer	3.36e-05	0.0007	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Etoposide—uterine cancer	3.33e-05	0.000695	CcSEcCtD
Hydrocortisone—Fatigue—Etoposide—uterine cancer	3.33e-05	0.000694	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—uterine cancer	3.33e-05	0.000693	CcSEcCtD
Hydrocortisone—Pain—Etoposide—uterine cancer	3.3e-05	0.000688	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—uterine cancer	3.27e-05	0.000682	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—uterine cancer	3.21e-05	0.000668	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—uterine cancer	3.19e-05	0.000664	CcSEcCtD
Hydrocortisone—Feeling abnormal—Etoposide—uterine cancer	3.18e-05	0.000663	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—uterine cancer	3.17e-05	0.000661	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Etoposide—uterine cancer	3.16e-05	0.000658	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—uterine cancer	3.14e-05	0.000655	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—uterine cancer	3.14e-05	0.000655	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—uterine cancer	3.1e-05	0.000646	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—uterine cancer	3.08e-05	0.000642	CcSEcCtD
Hydrocortisone—Urticaria—Etoposide—uterine cancer	3.07e-05	0.000639	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—uterine cancer	3.06e-05	0.000638	CcSEcCtD
Hydrocortisone—Abdominal pain—Etoposide—uterine cancer	3.05e-05	0.000636	CcSEcCtD
Hydrocortisone—Body temperature increased—Etoposide—uterine cancer	3.05e-05	0.000636	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—uterine cancer	3.05e-05	0.000635	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—uterine cancer	2.99e-05	0.000624	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—uterine cancer	2.87e-05	0.000598	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—uterine cancer	2.85e-05	0.000593	CcSEcCtD
Hydrocortisone—Hypersensitivity—Etoposide—uterine cancer	2.85e-05	0.000593	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—uterine cancer	2.83e-05	0.000591	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—uterine cancer	2.82e-05	0.000588	CcSEcCtD
Hydrocortisone—Asthenia—Etoposide—uterine cancer	2.77e-05	0.000577	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—uterine cancer	2.77e-05	0.000577	CcSEcCtD
Hydrocortisone—Testosterone—CYP19A1—uterine cancer	2.77e-05	0.0148	CrCbGaD
Hydrocortisone—Immune system disorder—Epirubicin—uterine cancer	2.75e-05	0.000574	CcSEcCtD
Hydrocortisone—Pruritus—Etoposide—uterine cancer	2.73e-05	0.000569	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—uterine cancer	2.72e-05	0.000567	CcSEcCtD
Hydrocortisone—Progesterone—ESR1—uterine cancer	2.69e-05	0.0144	CrCbGaD
Hydrocortisone—Dexamethasone—CYP19A1—uterine cancer	2.68e-05	0.0143	CrCbGaD
Hydrocortisone—Mental disorder—Epirubicin—uterine cancer	2.67e-05	0.000556	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—uterine cancer	2.65e-05	0.000553	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—uterine cancer	2.65e-05	0.000553	CcSEcCtD
Hydrocortisone—Diarrhoea—Etoposide—uterine cancer	2.64e-05	0.000551	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—uterine cancer	2.63e-05	0.000549	CcSEcCtD
Hydrocortisone—Dizziness—Etoposide—uterine cancer	2.55e-05	0.000532	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—uterine cancer	2.55e-05	0.000531	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—uterine cancer	2.52e-05	0.000525	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—uterine cancer	2.47e-05	0.000515	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—uterine cancer	2.46e-05	0.000513	CcSEcCtD
Hydrocortisone—Vomiting—Etoposide—uterine cancer	2.46e-05	0.000512	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—uterine cancer	2.45e-05	0.000511	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—uterine cancer	2.45e-05	0.000511	CcSEcCtD
Hydrocortisone—Rash—Etoposide—uterine cancer	2.43e-05	0.000507	CcSEcCtD
Hydrocortisone—Dermatitis—Etoposide—uterine cancer	2.43e-05	0.000507	CcSEcCtD
Hydrocortisone—Headache—Etoposide—uterine cancer	2.42e-05	0.000504	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—uterine cancer	2.39e-05	0.000498	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—uterine cancer	2.38e-05	0.000497	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—uterine cancer	2.38e-05	0.000496	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—uterine cancer	2.33e-05	0.000486	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—uterine cancer	2.3e-05	0.000479	CcSEcCtD
Hydrocortisone—Nausea—Etoposide—uterine cancer	2.29e-05	0.000478	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—uterine cancer	2.29e-05	0.000477	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—uterine cancer	2.28e-05	0.000475	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—uterine cancer	2.26e-05	0.000471	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—uterine cancer	2.25e-05	0.000469	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.24e-05	0.000467	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—uterine cancer	2.23e-05	0.000465	CcSEcCtD
Hydrocortisone—Malaise—Doxorubicin—uterine cancer	2.21e-05	0.000461	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—uterine cancer	2.2e-05	0.00046	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—uterine cancer	2.2e-05	0.000459	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—uterine cancer	2.16e-05	0.000451	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—uterine cancer	2.16e-05	0.000451	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—uterine cancer	2.16e-05	0.00045	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—uterine cancer	2.15e-05	0.000448	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—uterine cancer	2.13e-05	0.000444	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—uterine cancer	2.13e-05	0.000443	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—uterine cancer	2.12e-05	0.000442	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—uterine cancer	2.12e-05	0.000442	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—uterine cancer	2.11e-05	0.00044	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—uterine cancer	2.1e-05	0.000438	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—uterine cancer	2.09e-05	0.000436	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—uterine cancer	2.09e-05	0.000435	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—uterine cancer	2.08e-05	0.000434	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.07e-05	0.000432	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—uterine cancer	2.06e-05	0.00043	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—uterine cancer	2.06e-05	0.00043	CcSEcCtD
Hydrocortisone—Hypotension—Epirubicin—uterine cancer	2.02e-05	0.000422	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—uterine cancer	2e-05	0.000417	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—uterine cancer	2e-05	0.000417	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—uterine cancer	1.99e-05	0.000415	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.97e-05	0.000411	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—uterine cancer	1.97e-05	0.000411	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—uterine cancer	1.96e-05	0.000409	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—uterine cancer	1.96e-05	0.000408	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—uterine cancer	1.95e-05	0.000407	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—uterine cancer	1.95e-05	0.000405	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—uterine cancer	1.94e-05	0.000405	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—uterine cancer	1.94e-05	0.000404	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—uterine cancer	1.91e-05	0.000398	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—uterine cancer	1.91e-05	0.000397	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—uterine cancer	1.88e-05	0.000392	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—uterine cancer	1.87e-05	0.00039	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—uterine cancer	1.87e-05	0.000389	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—uterine cancer	1.87e-05	0.000389	CcSEcCtD
Hydrocortisone—Pain—Epirubicin—uterine cancer	1.85e-05	0.000386	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.82e-05	0.00038	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—uterine cancer	1.81e-05	0.000378	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—uterine cancer	1.8e-05	0.000375	CcSEcCtD
Hydrocortisone—Feeling abnormal—Epirubicin—uterine cancer	1.78e-05	0.000372	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—uterine cancer	1.77e-05	0.000369	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—uterine cancer	1.76e-05	0.000367	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—uterine cancer	1.74e-05	0.000363	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.73e-05	0.00036	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—uterine cancer	1.73e-05	0.00036	CcSEcCtD
Hydrocortisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.72e-05	0.00077	CbGpPWpGaD
Hydrocortisone—Urticaria—Epirubicin—uterine cancer	1.72e-05	0.000358	CcSEcCtD
Hydrocortisone—Pain—Doxorubicin—uterine cancer	1.71e-05	0.000357	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—uterine cancer	1.71e-05	0.000357	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—uterine cancer	1.71e-05	0.000357	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.71e-05	0.000764	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	1.7e-05	0.000762	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—POLD1—uterine cancer	1.68e-05	0.000754	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	1.68e-05	0.000752	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Doxorubicin—uterine cancer	1.65e-05	0.000344	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—uterine cancer	1.64e-05	0.000341	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—RRM2—uterine cancer	1.63e-05	0.000729	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.62e-05	0.000725	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	1.62e-05	0.000724	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKR1C3—uterine cancer	1.6e-05	0.000718	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Epirubicin—uterine cancer	1.59e-05	0.000332	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—uterine cancer	1.59e-05	0.000332	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—uterine cancer	1.58e-05	0.00033	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—uterine cancer	1.58e-05	0.00033	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—DCN—uterine cancer	1.58e-05	0.000708	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	1.58e-05	0.000706	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKR1C1—uterine cancer	1.58e-05	0.000705	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PGR—uterine cancer	1.56e-05	0.000699	CbGpPWpGaD
Hydrocortisone—Asthenia—Epirubicin—uterine cancer	1.55e-05	0.000324	CcSEcCtD
Hydrocortisone—Pruritus—Epirubicin—uterine cancer	1.53e-05	0.000319	CcSEcCtD
Hydrocortisone—NR3C1—Gene Expression—SUZ12—uterine cancer	1.53e-05	0.000683	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.5e-05	0.000673	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.5e-05	0.000672	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—YWHAE—uterine cancer	1.49e-05	0.000667	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CYP11A1—uterine cancer	1.49e-05	0.000667	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.48e-05	0.000665	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.48e-05	0.000665	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	1.48e-05	0.000663	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Epirubicin—uterine cancer	1.48e-05	0.000309	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—uterine cancer	1.48e-05	0.000308	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—SRD5A2—uterine cancer	1.47e-05	0.00066	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NDUFB11—uterine cancer	1.47e-05	0.00066	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.46e-05	0.000654	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.46e-05	0.000654	CbGpPWpGaD
Hydrocortisone—Asthenia—Doxorubicin—uterine cancer	1.44e-05	0.0003	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—uterine cancer	1.43e-05	0.000298	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—FBXW7—uterine cancer	1.43e-05	0.00064	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	1.42e-05	0.000638	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.42e-05	0.000637	CbGpPWpGaD
Hydrocortisone—Pruritus—Doxorubicin—uterine cancer	1.42e-05	0.000295	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—AKR1C3—uterine cancer	1.41e-05	0.00063	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—RRM2—uterine cancer	1.4e-05	0.000629	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.39e-05	0.000622	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.39e-05	0.000621	CbGpPWpGaD
Hydrocortisone—Vomiting—Epirubicin—uterine cancer	1.38e-05	0.000287	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—uterine cancer	1.37e-05	0.000286	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—uterine cancer	1.36e-05	0.000284	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.36e-05	0.000611	CbGpPWpGaD
Hydrocortisone—Dermatitis—Epirubicin—uterine cancer	1.36e-05	0.000284	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—DCN—uterine cancer	1.36e-05	0.00061	CbGpPWpGaD
Hydrocortisone—Headache—Epirubicin—uterine cancer	1.36e-05	0.000283	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—AKR1B1—uterine cancer	1.35e-05	0.000602	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—STAR—uterine cancer	1.35e-05	0.000602	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.33e-05	0.000596	CbGpPWpGaD
Hydrocortisone—Dizziness—Doxorubicin—uterine cancer	1.32e-05	0.000276	CcSEcCtD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.32e-05	0.000591	CbGpPWpGaD
Hydrocortisone—Nausea—Epirubicin—uterine cancer	1.29e-05	0.000268	CcSEcCtD
Hydrocortisone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.28e-05	0.000575	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CYP11A1—uterine cancer	1.28e-05	0.000575	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.28e-05	0.000573	CbGpPWpGaD
Hydrocortisone—Vomiting—Doxorubicin—uterine cancer	1.27e-05	0.000265	CcSEcCtD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.27e-05	0.00057	CbGpPWpGaD
Hydrocortisone—Rash—Doxorubicin—uterine cancer	1.26e-05	0.000263	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—uterine cancer	1.26e-05	0.000263	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—uterine cancer	1.25e-05	0.000262	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—STK11—uterine cancer	1.25e-05	0.000559	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL2—uterine cancer	1.24e-05	0.000557	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.24e-05	0.000556	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.23e-05	0.000551	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.22e-05	0.000548	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.22e-05	0.000547	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.21e-05	0.000544	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKR1C3—uterine cancer	1.21e-05	0.000543	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.2e-05	0.000539	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.2e-05	0.000539	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.19e-05	0.000533	CbGpPWpGaD
Hydrocortisone—Nausea—Doxorubicin—uterine cancer	1.19e-05	0.000248	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—SOCS3—uterine cancer	1.17e-05	0.000524	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.16e-05	0.000518	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.13e-05	0.000506	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.13e-05	0.000505	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN2B—uterine cancer	1.12e-05	0.000501	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—STK11—uterine cancer	1.1e-05	0.000491	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.000491	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.09e-05	0.000488	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IGF1R—uterine cancer	1.09e-05	0.000487	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCL8—uterine cancer	1.08e-05	0.000485	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKR1B1—uterine cancer	1.07e-05	0.000477	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—STAR—uterine cancer	1.07e-05	0.000477	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—STAR—uterine cancer	1.06e-05	0.000473	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.06e-05	0.000473	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—POLD1—uterine cancer	1.06e-05	0.000473	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.06e-05	0.000473	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.06e-05	0.000473	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.04e-05	0.000467	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.03e-05	0.000462	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.03e-05	0.000461	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SMAD3—uterine cancer	1.02e-05	0.000458	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKR1C1—uterine cancer	9.88e-06	0.000442	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCL8—uterine cancer	9.83e-06	0.00044	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.81e-06	0.000439	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FGFR2—uterine cancer	9.75e-06	0.000437	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—STK11—uterine cancer	9.45e-06	0.000423	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CYP19A1—uterine cancer	9.45e-06	0.000423	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SRD5A2—uterine cancer	9.15e-06	0.000409	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NDUFB11—uterine cancer	9.15e-06	0.000409	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	9.14e-06	0.000409	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	9.11e-06	0.000408	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	9.01e-06	0.000403	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.88e-06	0.000398	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.87e-06	0.000397	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—RRM2—uterine cancer	8.8e-06	0.000394	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—DCN—uterine cancer	8.55e-06	0.000383	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.46e-06	0.000379	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	8.42e-06	0.000377	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.39e-06	0.000376	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—POLD1—uterine cancer	8.36e-06	0.000374	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ESR1—uterine cancer	8.34e-06	0.000373	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—POLD1—uterine cancer	8.29e-06	0.000371	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—MTHFR—uterine cancer	8.24e-06	0.000369	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP11A1—uterine cancer	8.05e-06	0.00036	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SRD5A2—uterine cancer	7.97e-06	0.000357	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NDUFB11—uterine cancer	7.97e-06	0.000357	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—uterine cancer	7.89e-06	0.000353	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKR1C1—uterine cancer	7.82e-06	0.00035	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKR1C1—uterine cancer	7.75e-06	0.000347	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	7.69e-06	0.000344	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKR1B1—uterine cancer	7.63e-06	0.000342	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—STAR—uterine cancer	7.63e-06	0.000342	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKR1C3—uterine cancer	7.6e-06	0.00034	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PGR—uterine cancer	7.59e-06	0.00034	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCL2—uterine cancer	7.34e-06	0.000329	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.26e-06	0.000325	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—EZH2—uterine cancer	7.21e-06	0.000323	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—MTHFR—uterine cancer	7.1e-06	0.000318	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—RRM2—uterine cancer	6.97e-06	0.000312	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—RRM2—uterine cancer	6.91e-06	0.000309	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PIK3CA—uterine cancer	6.87e-06	0.000307	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—uterine cancer	6.79e-06	0.000304	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—DCN—uterine cancer	6.77e-06	0.000303	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—DCN—uterine cancer	6.71e-06	0.0003	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ESR2—uterine cancer	6.69e-06	0.000299	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.69e-06	0.000299	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKR1B1—uterine cancer	6.61e-06	0.000296	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—STAR—uterine cancer	6.61e-06	0.000296	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.54e-06	0.000293	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP11A1—uterine cancer	6.38e-06	0.000285	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP11A1—uterine cancer	6.32e-06	0.000283	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.26e-06	0.00028	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PIK3CA—uterine cancer	6.24e-06	0.000279	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.19e-06	0.000277	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ERBB2—uterine cancer	6.12e-06	0.000274	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKR1C3—uterine cancer	6.02e-06	0.00027	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—POLD1—uterine cancer	5.99e-06	0.000268	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKR1C3—uterine cancer	5.97e-06	0.000267	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	5.92e-06	0.000265	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—STK11—uterine cancer	5.92e-06	0.000265	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.85e-06	0.000262	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL8—uterine cancer	5.81e-06	0.00026	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—uterine cancer	5.77e-06	0.000258	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKR1B1—uterine cancer	5.76e-06	0.000258	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—STAR—uterine cancer	5.76e-06	0.000258	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.7e-06	0.000255	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1B—uterine cancer	5.67e-06	0.000254	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—uterine cancer	5.61e-06	0.000251	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKR1C1—uterine cancer	5.6e-06	0.000251	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.56e-06	0.000249	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CDKN2B—uterine cancer	5.44e-06	0.000244	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.44e-06	0.000243	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CTNNB1—uterine cancer	5.36e-06	0.00024	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.3e-06	0.000237	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTEN—uterine cancer	5.22e-06	0.000234	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—POLD1—uterine cancer	5.19e-06	0.000232	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.15e-06	0.000231	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—uterine cancer	5.09e-06	0.000228	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—RRM2—uterine cancer	4.99e-06	0.000224	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EP300—uterine cancer	4.98e-06	0.000223	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—SMAD3—uterine cancer	4.97e-06	0.000222	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.91e-06	0.00022	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.91e-06	0.00022	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKR1C1—uterine cancer	4.85e-06	0.000217	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—DCN—uterine cancer	4.85e-06	0.000217	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—uterine cancer	4.72e-06	0.000211	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—STK11—uterine cancer	4.69e-06	0.00021	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP19A1—uterine cancer	4.69e-06	0.00021	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—uterine cancer	4.66e-06	0.000209	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP19A1—uterine cancer	4.65e-06	0.000208	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—STK11—uterine cancer	4.65e-06	0.000208	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTEN—uterine cancer	4.58e-06	0.000205	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP11A1—uterine cancer	4.57e-06	0.000205	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—POLD1—uterine cancer	4.52e-06	0.000202	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—MTHFR—uterine cancer	4.45e-06	0.000199	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.38e-06	0.000196	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—EP300—uterine cancer	4.37e-06	0.000196	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—RRM2—uterine cancer	4.33e-06	0.000194	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKR1C3—uterine cancer	4.31e-06	0.000193	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKR1C1—uterine cancer	4.23e-06	0.000189	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—DCN—uterine cancer	4.2e-06	0.000188	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ESR1—uterine cancer	4.06e-06	0.000182	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.02e-06	0.00018	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—uterine cancer	4.01e-06	0.00018	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP11A1—uterine cancer	3.96e-06	0.000177	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTEN—uterine cancer	3.95e-06	0.000177	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.92e-06	0.000176	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.89e-06	0.000174	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—RRM2—uterine cancer	3.77e-06	0.000169	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—EP300—uterine cancer	3.77e-06	0.000169	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.74e-06	0.000167	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—uterine cancer	3.68e-06	0.000165	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—DCN—uterine cancer	3.66e-06	0.000164	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—uterine cancer	3.56e-06	0.00016	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.55e-06	0.000159	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—STAR—uterine cancer	3.55e-06	0.000159	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MTHFR—uterine cancer	3.53e-06	0.000158	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MTHFR—uterine cancer	3.49e-06	0.000156	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP11A1—uterine cancer	3.45e-06	0.000154	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—uterine cancer	3.41e-06	0.000153	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—STK11—uterine cancer	3.36e-06	0.00015	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.36e-06	0.00015	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.29e-06	0.000147	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKR1C3—uterine cancer	3.26e-06	0.000146	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—uterine cancer	3.23e-06	0.000145	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—uterine cancer	3.01e-06	0.000135	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—STK11—uterine cancer	2.91e-06	0.00013	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.91e-06	0.00013	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—uterine cancer	2.79e-06	0.000125	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—POLD1—uterine cancer	2.79e-06	0.000125	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.73e-06	0.000122	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—uterine cancer	2.64e-06	0.000118	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.61e-06	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.61e-06	0.000117	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—STK11—uterine cancer	2.54e-06	0.000114	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP19A1—uterine cancer	2.54e-06	0.000114	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MTHFR—uterine cancer	2.53e-06	0.000113	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTEN—uterine cancer	2.48e-06	0.000111	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—EP300—uterine cancer	2.36e-06	0.000106	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—RRM2—uterine cancer	2.32e-06	0.000104	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—uterine cancer	2.28e-06	0.000102	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—DCN—uterine cancer	2.25e-06	0.000101	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MTHFR—uterine cancer	2.19e-06	9.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.12e-06	9.51e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.01e-06	8.98e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTEN—uterine cancer	1.96e-06	8.78e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTEN—uterine cancer	1.94e-06	8.7e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.93e-06	8.63e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MTHFR—uterine cancer	1.91e-06	8.53e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—EP300—uterine cancer	1.87e-06	8.37e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—EP300—uterine cancer	1.85e-06	8.3e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.75e-06	7.82e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—STK11—uterine cancer	1.56e-06	7e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.56e-06	7e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—uterine cancer	1.46e-06	6.55e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—uterine cancer	1.43e-06	6.39e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTEN—uterine cancer	1.41e-06	6.29e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—uterine cancer	1.38e-06	6.19e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.37e-06	6.14e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—EP300—uterine cancer	1.34e-06	6e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTEN—uterine cancer	1.22e-06	5.45e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.17e-06	5.26e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—EP300—uterine cancer	1.16e-06	5.2e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—uterine cancer	1.13e-06	5.06e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—uterine cancer	1.12e-06	5.01e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTEN—uterine cancer	1.06e-06	4.75e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—EP300—uterine cancer	1.01e-06	4.53e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—uterine cancer	9.91e-07	4.44e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—uterine cancer	8.59e-07	3.84e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—uterine cancer	8.1e-07	3.63e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—uterine cancer	7.48e-07	3.35e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—uterine cancer	7.01e-07	3.14e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTEN—uterine cancer	6.53e-07	2.92e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EP300—uterine cancer	6.23e-07	2.79e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—uterine cancer	6.11e-07	2.74e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.61e-07	2.06e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—uterine cancer	3.76e-07	1.69e-05	CbGpPWpGaD
